Your browser doesn't support javascript.
loading
Cooled tip radiofrequency ablation of benign thyroid nodules: preliminary experience with two different devices.
Morelli, Francesco; Ierardi, Anna Maria; Pompili, Giovanni; Sacrini, Andrea; Biondetti, Pierpaolo; Angileri, Salvatore Alessio; Montesano, Giovanni; Petrillo, Mario; Giacchero, Roberta; Dionigi, Gianlorenzo; Carrafiello, Gianpaolo.
Afiliación
  • Morelli F; Department of Radiology, San Paolo Hospital, Milan, Italy.
  • Ierardi AM; Department of Radiology, San Paolo Hospital, Milan, Italy.
  • Pompili G; Department of Radiology, San Paolo Hospital, Milan, Italy.
  • Sacrini A; Department of Radiology, San Paolo Hospital, Milan, Italy.
  • Biondetti P; Department of Radiology, San Paolo Hospital, Milan, Italy.
  • Angileri SA; Department of Radiology, San Paolo Hospital, Milan, Italy.
  • Montesano G; Department of Ophthalmology, San Paolo Hospital, Milan, Italy.
  • Petrillo M; Department of Radiology, San Paolo Hospital, Milan, Italy.
  • Giacchero R; Curie Diagnostical Medical Center, Cologno Monzese, Italy.
  • Dionigi G; Department of Pediatrics, San Paolo Hospital, Milan, Italy.
  • Carrafiello G; Department of Human Pathology in Adulthood and Childhood "G. Barresi", University Hospital G. Martino, University of Messina, Messina, Italy.
Gland Surg ; 7(2): 67-79, 2018 Apr.
Article en En | MEDLINE | ID: mdl-29770303
ABSTRACT

BACKGROUND:

Thyroid nodules are very common in general population. Even if benign, they may require a treatment in case of symptoms or cosmetic concerns. In the last years, minimally invasive treatments alternative to surgery have been developed, in particular ultrasound (US) guided radiofrequency ablation (RFA).

METHODS:

Twenty-four patients (9 males; 15 females; mean age 57.9 years) were treated and divided in two groups (A and B) according to the RFA needle used (18 gauge needle, AMICA; 17 gauge needle, COVIDIEN). Nodules and patients characteristics, together with procedural data were registered pre-treatment and at 1-month follow-up. US visibility of the needle, volume of the nodules, symptoms and cosmetic concerns, complications were registered.

RESULTS:

Visibility of the needle was not significantly different in the two groups (P=0.0787). At 1 month the mean volume of the nodules dropped from 37.1 to 25 mL in group A and from 23.2 to 15.4 mL in group B; shrinkage rate (36.9% and 39.5%, respectively) was not significantly different (P=0.3137). Symptoms decreased from 3.1 to 1.4 in group A and from 4 to 1.6 in group B no significant differences in reductions were observed (P=0.3305). Cosmetic score decreased from 3.7 to 3.4 in group A and from 3.9 to 3.6 in group B no significant differences in reductions were observed (P=0.96). Total complication rate (18.2% in group A vs. 23.1% in group B) did not showed significant differences (P=0.5049).

CONCLUSIONS:

The two systems used in our study resulted equivalent in terms of US needle visibility, efficacy, symptom/cosmetic relief, safety. More patients and a longer follow-up are necessary to confirm our results.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Gland Surg Año: 2018 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Gland Surg Año: 2018 Tipo del documento: Article País de afiliación: Italia
...